Table 3 Number of patients involved in the study per centre
Paediatric Centre Investigator | # Patients interviewed | # Patients 0–5 y.o | # Patients / 6–11 y.o | # Patients 12–15 y.o | # Patients 16–19 y.o |
|---|---|---|---|---|---|
P1 | P2 | P3 | P4 | ||
Lille Paediatric | 3 | 1 | 1 | 1 | – |
Paris R. Debré | 5 | – | 3 | – | 2 |
Strasbourg Paediatric | 5 | 2 | – | 2 | 1 |
Saint-Pierre LR | 5 | 1 | 2 | 1 | 1 |
Rennes Paediatric | 6 | 2 | 1 | 2 | 1 |
Bordeaux Paediatric | 3 | 1 | 1 | 1 | – |
Grenoble Paediatric | 4 | 1 | 2 | 1 | – |
S/TOTAL Paediatric | 31 | 8 | 10 | 8 | 5 |
Adult Centre Investigator | # Patients interviewed | # CF Patients 18–22 y.o | # CF Patients / 22 + y.o | # Transplant Patients | Of whom # Patients with child |
|---|---|---|---|---|---|
P10 | P11-P12-13 | P19-20 | P15-16 | ||
Lille Adult | 12 | 2 | 7 | 3 | 3 |
Nantes Adult | 10 | 2 | 3 | 5 | 4 |
Lyon Adult | 6 | 1 | 3 | 2 | 3 |
Clermont-Ferrand | 6 | 2 | 3 | 1 | 3 |
Other CF centres | 2 | – | – | 2 | 2 |
S/TOTAL Adults | 36 | 8 | 15 | 13 | 15 |
TOTAL | 67 | ||||